Me on 5 milligrams of Finasteride, off label oral Min, a $3000 red light therapy cap, experimental Russian drugs, and three Turkish hair transplants watching a 60 year old homeless man with a perfect hairline smoke crack Satire 3/30/2025
The conversation humorously discusses the unfairness of hair loss, highlighting various treatments like finasteride, minoxidil, red light therapy, and experimental drugs, while contrasting with people who have great hair despite unhealthy lifestyles. The original poster mentions experiencing side effects from switching to oral finasteride.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity A little more than a month using red light therapy. I'm surprised by the progress.
Red light therapy has shown promising results in hair regrowth for the user, who avoids minoxidil and finasteride due to side effects. The user follows a healthy lifestyle with diet, exercise, and sauna use, and will continue monitoring the therapy's effectiveness.
community Don't be inconsistent with Minoxidil, you will lose progress fast. My new plan for future.
Inconsistent minoxidil use led to hair loss, prompting a plan to resume consistent application with derma stamping, red light therapy, and DHT blockers like clascoterone or RU58841. The user avoids finasteride and dutasteride due to past side effects.
community Hairloss has destroyed my Life completely
A young person is distressed about rapid hair loss despite using finasteride and recently starting oral minoxidil. Many suggest continuing treatment, considering dutasteride, and seeking therapy for mental health support.
community Hair loss treatment iceberg: what does it look like?
Hair loss treatments range from common options like biotin, minoxidil, and finasteride to more obscure methods like RU58841 and experimental drugs. Hair transplants are widely known, while treatments like stool transplants and spironolactone are less common.
community Bryan (the guy who reversed aging) shares treatment that reversed his hair loss
A person improved hair loss from Norwood 3 to Norwood 2 using a topical formula with minoxidil, dutasteride, and tretinoin, plus oral minoxidil and red light therapy. There is skepticism about the treatment's effectiveness and concerns about misleading comparison photos.
Related Research
6 / 6 resultsresearch Androgenetic Alopecia: Therapy Update
This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
research Treatments options for alopecia
This article discusses the social and psychological impact of hair disorders and the challenges in their treatment, but reports no new clinical results.
research Physiology and Medical Treatments for Alopecia
This abstract explains that androgenetic alopecia, a common hair loss disorder influenced by genetics and hormones like dihydrotestosterone, has FDA-approved treatments including minoxidil, finasteride, and photolaser therapy, but its genetic basis and susceptibility to environmental factors remain complex.
research Medical Management Options for Hair Loss
This review discusses both conventional and new pharmaceutical treatments for hair loss, as well as various natural and herbal remedies, but reports no new clinical results.
research Androgenetic alopecia - a literature review
This review highlights that while finasteride and minoxidil effectively treat androgenetic alopecia, emerging options like dutasteride, mesotherapy, androgen blockers, and red LED therapy show promising results, especially when used in combination, though further research is needed for standardization and safety confirmation.
research Controversy: is there a role for adjuvants in the management of male pattern hair loss?
This article reviews current hair loss treatments, proposing a hypothesis that a combination of drugs, supplements, and therapies may effectively manage hair loss, but presents no new clinical results.